Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity-Reference-Cited by-同舟云学术

Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity

Published:2020-10-01 Issue:2 Volume:197 Page:133-140
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Franzese Ciro^ORCID,Badalamenti Marco,Baldaccini Davide,D’Agostino Giuseppe,Comito Tiziana,Franceschini Davide,Clerici Elena,Navarria Pierina,Reggiori Giacomo,Tomatis Stefano,Scorsetti Marta

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00066-020-01691-z.pdf

Reference22 articles.

1. Schröder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13):1320–1328. https://doi.org/10.1056/NEJMoa0810084

2. National Comprehensive Cancer Network (2019) NCCN clinical practice guidelines in oncology: prostate cancer 2019. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

3. Thompson IM, Tangen CM, Paradelo J et al (2006) Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. J Am Med Assoc 296(19):2329–2335. https://doi.org/10.1001/jama.296.19.2329

4. Wiegel T, Bottke D, Steiner U et al (2009) Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 27(18):2924–2930. https://doi.org/10.1200/JCO.2008.18.9563

5. Bolla M, van Poppel H, Tombal B et al (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 380(9858):2018–2027. https://doi.org/10.1016/S0140-6736(12)61253-7

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 10-yr Results of Moderately Hypofractionated Postoperative Radiotherapy for Prostate Cancer Focused on Treatment Related Toxicity;Clinical Genitourinary Cancer;2024-08

2. Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy;Advances in Radiation Oncology;2023-03

3. Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-01

4. Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy;Strahlentherapie und Onkologie;2022-03-13

5. Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules;Neoplasma;2022